FF
GILD icon

Friedenthal Financial’s Gilead Sciences GILD Stock Holding History

Friedenthal Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,152
Closed -$1.01M – 296
2025
Q2 		$1.01M Buy
+9,152
New +$974K 0.56% 33
2025
Q1 		– Sell
-537
Closed -$49.6K – 253
2024
Q4 		$49.6K Sell
537
-58
-10% -$5.22K 0.03% 167
2024
Q3 		$49.9K Buy
+595
New +$45.4K 0.03% 157
2023
Q1 		– Sell
-8,959
Closed -$769K – 124
2022
Q4 		$769K Buy
+8,959
New +$709K 0.54% 52

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Friedenthal Financial's GILD Position: Q3 2025 in Review

Friedenthal Financial sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 9,152 shares — an estimated $1.01M sold.

Friedenthal Financial first reported a position in GILD in Q4 2022 and held it in 4 quarters. The position peaked at $1.01M in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Friedenthal Financial reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Friedenthal Financial sold 9,152 Gilead Sciences shares in Q3 2025, an estimated $1.01M.
  • Friedenthal Financial first reported a position in Gilead Sciences in Q4 2022 and held it in 4 quarters.
  • Friedenthal Financial's Gilead Sciences position peaked at $1.01M in Q2 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Friedenthal Financial's 13F filing for Q3 2025, filed 15 Oct 2025.